2Ressing ME.Sette A.Brandt RM.et al.Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A·0201-binding peptides.J Immunol.1995.154(11):5934-5943.
3Ulmer JB.Donnelly JJ.Parker SE.et al.Heterologous protection against influenza by injection of DNA encoding a viral protein.Science.1993.259(5102):1745-1749.
4Tuting T.Deleo AB.Lotze MT.et al.Genetically modified bone marrowderived dendritic cells exxpressing tumor-associated viral of self antigens induce antitumor immunity in vivo.Eur J Immunol.1997.27(10):2702-2707.
5Tillman BW.Hayes TL,DeGruijl TD.et al.Adenoviral vectors largeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model.Cancer Res.2000.60(19):5456-5463.
6Ji H.Wang TL.Chen CH.et al'.Targeting human papillomavirus type 16 E7 to the endoscmal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine hman papillomavirus type 16 E7-expressing tumors.Hum Gene Ther.1999.10(17):2727-2740.
7Tbomburg C.Boczkowski D Gilboa E,et al.Induction of cytotoxic T lymphocytes tith dendritic cells transpected with human papillomavirus E6 and E7 rna:implications for cervical cancer immunotherapy.J Immunother.2000.23(4):412-418.
8Cheng WF.Hung CF.Hsu KF.et al.Enhancement of sindbis virus selfreplicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments.Hum Gene Ther.2001.12(3):235-252.
9Santin AD.Hermonat PL.Ravaggi A.et al.Induction of human papillomavirus-specific CD4(+)and CD8(+)lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16-and 18-positive cervical cancer.J Virol.1999.73(7):5402-5410.
10Murakami M.Gurski KJ.Marincola FM.et al.Induction of specific CD8+ T-lymphocyte responses using a human papillomavirus-16 E6/E7 fusion protein and autologous dendritic cells.Cancer Res.1999.59(6):1184-1187.
